Informação sobre produto
GSK2850163 is a small molecule that has been identified by GSK as a potential drug target for cancer. The compound inhibits the AMP-activated protein kinase, which is involved in cell growth and proliferation. GSK2850163 has been shown to inhibit the uptake of glucose in human muscle cells, which may be due to its ability to form hydrogen bonds with microenvironmental molecules. The compound also binds to the endoplasmic reticulum and prevents the hydrolysis of ATP, which leads to an increase in intracellular calcium levels. GSK2850163 has also been shown to have an effect on brucella bacteria. It can be used as a potential drug treatment for lymphocytic leukemia, as it blocks the growth of myeloid cells that are responsible for this disease.
Propriedades químicas
Consulta técnica sobre: 3D-WJD98991 GSK2850163
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
